Stimulation by angiotensins I and II of ACTH release from goldfish pituitary cell columns

Differential status of the renin-angiotensin system of silver sea bream (Sparus sarba) in different salinities

Silver sea bream (Sparus sarba) is extremely euryhaline and can survive in a wide range of salinities (0-70 per thousand). The status of the renin-angiotensin system (RAS) in sea bream adapted to different salinities was studied. As indicated by plasma Ang II levels, a suppressed status of the RAS was found to occur under brackish water conditions; while under hypersaline conditions, an activated RAS prevailed, especially in fish adapted to double strength seawater (70 per thousand). Captopril successfully blocked the conversion of Ang I to Ang II, causing a dramatic drop in plasma Ang II levels, and such decrease was accompanied by lowered plasma cortisol levels. The pattern of changes in branchial Na-K-ATPase activity in different salinities was similar to those of plasma Ang II and cortisol, suggesting a causal regulatory role of Ang II on branchial Na-K-ATPase activity. Intraperitoneal injection of Ang II elicited a dose-dependent increase in branchial Na-K-ATPase activity in both 33- and 6 per thousand-adapted sea bream, but a relatively more intense stimulation of enzyme activity occurred in hyposmotic-adapted fish. Abrupt hyposmotic transfer rapidly lowered plasma Ang II level but elevated branchial Na-K-ATPase and transiently elevated plasma cortisol, indicating that these parameters are not solely controlled by Ang II but are also influenced by other hormonal factors that change during salinity transfer. Blood volumes of both 33- and 6 per thousand-adapted sea bream exhibited high stability during short-term salinity transfers and after long-term salinity adaptation. Captopril significantly reduced resting blood pressure in both 33- and 6 per thousand-adapted sea bream, indicating that the RAS was involved in maintenance of resting blood pressure in both hyperosmotic and hyposmotic environments. Blood pressure was highly stable during abrupt salinity transfer and captopril blockade did not alter such stability. The vasopressive effect of angiotensins was more potent in 6 per thousand-adapted sea bream. These results showed that the RAS is involved in the maintenance of fluid and pressure homeostasis in sea bream and hyposmotic-adapted sea bream has an abated RAS status.

Structural and functional evolution of the natriuretic peptide system in vertebrates

The natriuretic peptide (NP) system consists of three types of hormones [atrial NP (ANP), brain or B-type NP (BNP), and C-type NP (CNP)] and three types of receptors [NP receptor (R)-A, NPR-B, and NPR-C]. ANP and BNP are circulating hormones secreted from the heart, whereas CNP is basically a neuropeptide. NPR-A and NPR-B are membrane-bound guanylyl cyclases, whereas NPR-C is assumed to function as a clearance-type receptor. ANP, BNP, and CNP occur commonly in all tetrapods, but ventricular NP replaces BNP in teleost fish. In elasmobranchs, only CNP is found, even in the heart, suggesting that CNP is an ancestral form. A new guanylyl cyclase-uncoupled receptor named NPR-D has been identified in the eel in addition to NPR-A, -B, and -C. The NP system plays pivotal roles in cardiovascular and body fluid homeostasis. ANP is secreted in response to an increase in blood volume and acts on various organs to decrease both water and Na+, resulting in restoration of blood volume. In the eel, however, ANP is secreted in response to an increase in plasma osmolality and decreases Na+ specifically, thereby promoting seawater adaptation. Therefore, it seems that the family of NPs were originally Na(+)-extruding hormones in fishes; however, they evolved to be volume-depleting hormones promoting the excretion of both Na+ and water in tetrapods in which both are always regulated in the same direction. Vertebrates expanded their habitats from fresh water to the sea or to land during evolution. The structure and function of osmoregulatory hormones have also undergone evolution during this ecological evolution. Thus, a comparative approach to the study of the NP family affords new insights into the essential function of this osmoregulatory hormone.

Localization of binding sites for atrial natriuretic factor and angiotensin II in the central nervous system of the clawed toad Xenopus laevis

The distribution of binding sites for atrial natriuretic factor (ANF) and angiotensin II (A II) was investigated in the central nervous system (CNS) of the clawed toad Xenopus laevis by means of in vitro autoradiography using [125I]-rat ANF(99-126) or [125I] [Val5] A II and [125I]human A II as labeled ligands. The highest densities of specific ANF-binding were detected in the nucleus habenularis, thalamic regions, hypophyseal pars nervosa and nucleus interpeduncularis. Moderate ANF-binding was found in the bulbus olfactorius, pallium, septum, striatum, lateral forebrain bundle, nucleus infundibularis, hypophyseal pars distalis and tectum. The highest levels of specific A II binding sites were observed in the nucleus praeopticus, nucleus habenularis, hypophyseal pars nervosa and pars distalis, whereas the amygdala contained moderate A II binding. The existence of specific binding sites for ANF and A II in the CNS of Xenopus laevis suggests that both peptides act as neurotransmitters or neuromodulators in the amphibian CNS. The co-localization of dense binding sites for both peptides in the nucleus habenularis, hypophyseal pars nervosa and pars distalis supports the view that ANF and A II have opposite regulatory functions in these regions.

Changes in arginine vasotocin content in the pituitary of the Medaka (Oryzias latipes) during osmotic stress

Changes in the arginine vasotocin (AVT) neurons of the medaka, Oryzias latipes, during osmotic stress were studied by means of immunohistochemistry and radioimmunoassay. AVT neurons were identified by their immunoreactivity to anti-arginine vasopressin serum, which crossreacts with AVT. When freshwater (FW)-adapted fish were transferred to seawater (SW), the number of immunoreactive magnocellular neurons decreased, while the cell nuclear size increased. AVT content in the pituitary significantly decreased 2 hr or 1 day after transfer to SW, but returned to approximately the initial level 1 week after transfer. However, when SW-adapted fish were transferred to FW, the number of immunoreactive magnocellular neurons increased from 1 hr after readaptation to FW, but the cell nuclear size failed to show significant changes. AVT content in the pituitary significantly increased 1 or 2 hr after transfer. These results seem to indicate that AVT secretion in the medaka was temporarily accelerated by exposure to SW and inhibited immediately after transfer to FW.

Isolation, Amino-Acid Sequence, Synthesis and Biological Properties of Urotensin I from Hippoglossoides elassodon

Abstract A 41-residue urotensin I neuropeptide (H-UI) was isolated from urophyses of the marine teleost Hippoglossoides elassodon (the flathead sole). The peptide was recognized by its partial cross-reactivity in a radioimmunoassay developed for Catostomus (sucker) Ul (S-UI), and was purified by reversed-phase high-performance liquid chromatography. The amino-acid sequence was shown to be H-Ser-Glu-Glu-Pro-Pro-Met-Ser-lle-Asp-Leu-Thr-Phe-His-Met-Leu-Arg-Asn-Met-lle-His-Arg-Ala-Lys-Met-Glu-Gly-Glu-Arg-Glu-Gln-Ala-Leu-lle-Asn-Arg-Asn-Leu-Leu-Asp-Glu-Val-NH(2). H-UI is 66% homologous with S-UI and 63% homologous with Cyprinus (carp) Ul (C-UI). Like S- and C-UI, H-UI is about 50% homologous with the frog skin peptide sauvagine and with Catostomus and mammalian corticotropin-releasing factors. H-UI had similar vasodilatory effects in mammals, and similar adrenocorticotropin-releasing effects (in rat and goldfish) to S-UI, C-UI, sauvagine and the corticotropin-releasing factors, but had relatively low potency (e.g. 10% to 30% of the vasodilatory potency of S- and C-UI) in all the bioassay systems studied.

The renin-angiotensin system and the regulation of plasma cortisol in the flounder, Platichthys flesus

The changes in arterial blood pressure and plasma cortisol concentration in response to exogenous angiotensin II (AII) and to manipulation of the endogenous renin-angiotensin system (RAS) have been examined in the flounder, Platichthys flesus. Intravenous [Asp1Val5]AII was pressor in a dose-dependent manner over the range of 0.25-250 micrograms/kg. Sequential blood sampling revealed steroidogenic stimulation, measured as change in plasma cortisol concentration, by doses of AII greater than 2.5 micrograms/kg. Enhanced circulating cortisol levels were measured some time after recovery of normal systemic blood pressure, suggesting that the change in plasma steroid concentration was not entirely dependent on the change in systemic blood pressure. Administration of the vasodilator papaverine produced immediate hypotension followed by gradual recovery in blood pressure, which was accompanied by a sustained increment in circulating cortisol. Both blood pressure recovery and the increased plasma steroid concentration were inhibited by prior treatment with the angiotensin converting enzyme inhibitor captopril. These results are consistent with a physiologically important role for the RAS in the control of plasma cortisol levels which complements its demonstrated pressor and dipsogenic actions in the flounder: the RAS may thus afford an integrating influence on the mechanisms of body fluid homeostasis in this euryhaline species.

Neuropeptides regulating the activity of goldfish corticotropes and melanotropes

The goldfish (Carassius auratus) has proven an advantageous model for investigations of the neuroendocrine regulation of pituitary hormone secretion in teleost fishes. Investigations examining the secretion of adrenocorticotropin (ACTH) and melanocyte-stimulating hormone (MSH) from pituitary cellsin vitro have been used to identify neuropeptides influencing goldfish corticotrope and melanotrope activity. Ovine CRF, urotensin I (UI), arginine vasotocin (AVT), isotocin and angiotensins I and II stimulate the release of ACTH from corticotropesin vitro. Thyrotropin-releasing hormone (TRH), oCRF, UI and neuropeptide Y stimulate the release of MSH from melanotropesin vitro. Immunocytochemical studies have revealed the presence of separate CRF- and UI-immunoreactive perikarya in the hypothalamus suggesting the existence of two structurally similar, yet distinct, hypothalamic CRF-UI-like peptides. Interactions of AVT and CRF in the regulation of ACTH secretion is suggested from studies demonstrating the co-localization of AVT- and CRF-immunoreactivities in perikarya of the preoptic-hypophyseal system. These investigations demonstrate that the secretory activity of goldfish corticotropes and melanotropes is influenced by a diversity of neuropeptides of hypothalamic origin.

Angiotensin II stimulation of teleost adrenocorticotropic hormone release: interactions with urotensin I and corticotropin-releasing factor

The release of adrenocorticotropic hormone (ACTH) from dispersed goldfish anterior pituitary cells was examined in order to determine whether human angiotensin II (AII) would potentiate the ACTH-releasing activity of urotensin I (UI) and ovine corticotropin-releasing factor (oCRF), peptides with a sequence homology of greater than 50%. In mammals, AII has a slightly enhancing or potentiating effect on CRF-stimulated ACTH release. In the present investigations, concentrations of AII (0.5 and 1 nM), and of UI (1 nM) or oCRF (3 nM), which elicit moderate increases in ACTH release, were tested alone and in combination. The ACTH-releasing activities of AII and UI combined, or of AII and oCRF combined, showed no potentiation and in fact were less than additive. It was concluded that AII does not potentiate the ACTH-releasing activity of either UI or oCRF observed with goldfish anterior pituitary cells in vitro.